Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Polivy. Always confirm against the full prescribing information.
100 interactions
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Polatuzumab vedotin.
Level 1 evidence
Apalutamide
The risk or severity of adverse effects can be decreased when Apalutamide is combined with Polatuzumab vedotin.
Level 1 evidence
Aprepitant
The metabolism of Polatuzumab vedotin can be decreased when combined with Aprepitant.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Polatuzumab vedotin is combined with Articaine.
Level 1 evidence
Atazanavir
The risk or severity of adverse effects can be increased when Atazanavir is combined with Polatuzumab vedotin.
Level 1 evidence
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Polatuzumab vedotin.
Level 1 evidence
Benzocaine
The risk or severity of methemoglobinemia can be increased when Polatuzumab vedotin is combined with Benzocaine.
Level 1 evidence
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Polatuzumab vedotin is combined with Benzyl alcohol.
Level 1 evidence
Berotralstat
The metabolism of Polatuzumab vedotin can be decreased when combined with Berotralstat.
Level 2 evidence
Bupivacaine
The risk or severity of methemoglobinemia can be increased when Polatuzumab vedotin is combined with Bupivacaine.
Level 1 evidence
Butamben
The risk or severity of methemoglobinemia can be increased when Polatuzumab vedotin is combined with Butamben.
Level 1 evidence
Capsaicin
The risk or severity of methemoglobinemia can be increased when Polatuzumab vedotin is combined with Capsaicin.
Level 1 evidence
Enter your NPI to unlock 1 major interaction for Polivy
Polivy (Polatuzumab Vedotin) has 280 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Polivy (Polatuzumab Vedotin) has 1 major, 112 moderate, and 167 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Polivy. Always confirm against the full prescribing information.